These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current Treatment Considerations for Osteosarcoma Metastatic at Presentation. Tsukamoto S; Errani C; Angelini A; Mavrogenis AF Orthopedics; 2020 Sep; 43(5):e345-e358. PubMed ID: 32745218 [TBL] [Abstract][Full Text] [Related]
4. [Standards and Options for the use of radiation therapy in the management of patients with osteosarcoma. Update 2004]. Claude L; Rousmans S; Carrie C; Breteau N; Dijoud F; Gentet JC; Giammarile F; Jouve JL; Kind M; Marec-Bérard P; Mascard E; Bataillard A; Philip T; ; ; ; ; ; Cancer Radiother; 2005 Mar; 9(2):104-21. PubMed ID: 15880886 [TBL] [Abstract][Full Text] [Related]
5. Treatment recommendations for osteosarcoma and adult soft tissue sarcomas. Picci P; Ferrari S; Bacci G; Gherlinzoni F Drugs; 1994 Jan; 47(1):82-92. PubMed ID: 7510623 [TBL] [Abstract][Full Text] [Related]
7. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Bacci G; Ferrari S; Mercuri M; Bertoni F; Picci P; Manfrini M; Gasbarrini A; Forni C; Cesari M; Campanacci M Acta Orthop Scand; 1998 Jun; 69(3):230-6. PubMed ID: 9703394 [TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of osteogenic sarcoma in children]. Pashkov Iu Vopr Onkol; 1989; 35(10):1155-60. PubMed ID: 2688308 [No Abstract] [Full Text] [Related]
15. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167 [TBL] [Abstract][Full Text] [Related]
16. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS). Winkler K; Bielack SS; Delling G; Jürgens H; Kotz R; Salzer-Kuntschik M Cancer Treat Res; 1993; 62():269-77. PubMed ID: 7682088 [TBL] [Abstract][Full Text] [Related]
17. [Recent advances in the treatment of childhood osteosarcoma: therapeutic modalities at the M.D. Anderson Hospital and Tumor Institute]. Takaue Y; Jaffe N Gan To Kagaku Ryoho; 1987 Jan; 14(1):38-43. PubMed ID: 3467656 [TBL] [Abstract][Full Text] [Related]
18. The value of adjuvant chemotherapy in the management of sarcomas in children. Donaldson SS Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137 [TBL] [Abstract][Full Text] [Related]
19. [Malignant bone tumours in children and adolescent]. Bollini G; Kalifa C; Panuel M Arch Pediatr; 2006 Jun; 13(6):669-71. PubMed ID: 16697603 [No Abstract] [Full Text] [Related]
20. Osteogenic sarcoma treatment overview and some comments on interpretation of clinical trial data. Carter SK; Friedman M Cancer Treat Rep; 1978 Feb; 62(2):199-204. PubMed ID: 346208 [No Abstract] [Full Text] [Related] [Next] [New Search]